Cancer.Net is pleased to offer its patient information on cancer research, treatment, coping, and many other topics in an audio podcast format. This gives people with cancer, and their families and friends, an additional option of how they'd like to receive oncologist-approved information from Cancer.Net.
The Cancer.Net Podcasts series has been awarded a Merit Award in the Digital Health Awards competition, which recognizes high-quality digital health resources for consumers and health professionals. The awards are organized by the Health Information Resource Center. Learn more about Cancer.Net awards and recognition.
A Cancer.Net Podcast is a pre-recorded audio file in which a specific cancer-related topic is addressed in order to assist people with cancer. A podcast can be listened to online (through the Internet) or downloaded to your computer free of charge. After downloading, a Cancer.Net Podcast may also be transferred to an MP3 audio player, such as an iPod. To download or listen to a Cancer.Net Podcast on your computer, you will need software capable of playing MP3 files, such as Windows Media Player or QuickTime. In addition, full written transcripts are available--click on the title of a podcast to read its transcript.
You may also want to subscribe to Cancer.Net Podcasts, so that new offerings are automatically downloaded to your personal computer as soon as they are available. To subscribe, copy-and-paste the link below into software that allows podcast subscriptions, such as iTunes or Juice.
In today’s podcast, Cancer.Net Associate Editor Dr. Brian Rini discusses some of the new research on kidney and bladder cancer presented at the 2016 ASCO Annual Meeting.
In today’s podcast, ASCO’s Chief Medical Officer, Dr. Richard Schilsky, discusses ASCO’s first-ever clinical trial, the Targeted Agent and Profiling Utilization Registry, or TAPUR Study. The TAPUR Study is a clinical trial for people with later-stage cancer, focused on whether specific targeted therapies can benefit more patients and lead to more personalized treatments. Dr. Schilsky explains the objectives of the study, and provides information about who might be eligible to participate, as well as what is involved.
In today’s podcast, Cancer.Net Associate Editor Dr. Kavitha Ramchandran discusses new research from the 2016 ASCO Annual Meeting on improving the quality of life for people living with cancer, as well as research on improving the overall quality of cancer care.
In today’s podcast, Cancer.Net Associate Editor Dr. Charles Loprinzi discusses some of the new research that came out of the 2016 ASCO Annual Meeting on how to better manage side effects of cancer treatment, including peripheral neuropathy, fatigue, nausea and vomiting, and skin rash. He also discusses several studies on the benefits of early palliative care during cancer treatment.
In today’s podcast, Dr. Apostolia-Maria Tsimberidou discusses several areas of current cancer research—including immunotherapy and precision, or personalized, medicine—that were highlighted at the 2016 American Association for Cancer Research Annual Meeting, held April sixteenth through twentieth in New Orleans, Louisiana.
In this podcast, Dr. Ezra Cohen discusses some of the research presented at the 2016 Multidisciplinary Head and Neck Cancer Symposium, held February eighteenth through twentieth in Scottsdale, Arizona.
In today’s podcast, we’ll discuss new research presented at the 2016 Quality Care Symposium, held February 26-28. This symposium brings together multidisciplinary leaders to share strategies and methods for measuring and improving the quality and safety of cancer care. The three studies highlighted in this podcast explore different ways to make sure patients are getting the most appropriate care, while minimizing the costs of cancer care.
In this podcast, Dr. Smitha Krishnamurthi discusses three studies highlighted at the 2016 Gastrointestinal Cancers Symposium, which examined two new treatment options for people with advanced neuroendocrine tumors and a new pre-surgical treatment option for people with locally advanced rectal cancer.
In today’s podcast, Dr. Sumanta Pal discusses one study highlighted at the 2016 Genitourinary Cancers Symposium that examines whether regular aspirin use lowers the risk of dying from prostate cancer.
In today’s podcast, we’ll discuss some of the new research that was presented at the 2015 San Antonio Breast Cancer Symposium, held December eighth through twelfth in San Antonio, Texas. This podcast will be led by Cancer.Net Associate Editor, Dr. Erica Mayer.